Anybody know whats happening at the Merck Newhouse site?
Merck
Conference on 7th Annual Biosimilars
Submitted by bharatbookseo on Sat, 19/06/2010 - 10:40- Analytical Technologies
- Barcelona
- Biogen Idec
- Biopharmaceuticals
- Biotechnology
- BsG Conference Centre
- David Goldsmith
- drug delivery
- Duncan Curley
- European Union
- Fernando de Mora
- Gillian Cannon
- Guy’s Hospital
- Health Economics
- Hospital
- Jo Pisani
- London
- Merck
- Michael Dilger
- Mohamed Oubihi
- National Institute
- National Institute for Biological Standards and Control
- NHS
- Person Career
- PricewaterhouseCoopers LLP
- Process Control
- Robin Thorpe
- Simon-Kucher
- St Thomas’ NHS Foundation Hospital
- Tikhe Pharma
- United Kingdom
- Universitat
Conference on 7th Annual Biosimilars
Optimising commercial strategies to develop Biosimilars and Biobetters
5th - 7th October 2010, BsG Conference Centre, London, UK
Key Speakers
Dr Gillian Cannon, Executive Director - Commercial Operations, Merck Bioventures,
Mohamed Oubihi, Senior Manager, International Regulatory Affairs, Biogen Idec,
Conference on Biobanking Americas
Submitted by bharatbookseo on Sat, 05/06/2010 - 09:15- Adel Laoui
- Americas
- bioinformatics
- Boston
- Brenda Yanak
- Business Development
- Coppersmith Schermer
- drug discovery
- Elaine W. Gunter
- FDA
- Food Safety
- Franchise Biology
- Hartmut Juhl
- Healthcare Technologies Aging Therapeutic
- IBM
- Indivumed
- Institute of Biomedical Technology
- James Eliason
- Jeff Milton
- John G. Baust
- Kristen Rosati
- Life Sciences
- Marc Allard
- Merck
- Michael Hehenberger
- National Cancer Institute
- Person Career
- Richard J. Maguire
- siRNA
- Specimen Solutions LLC
- State University of New York
- State University of New York
- Stem Cell
- Stem Cell Commercialization Center
- Thomas J. Watson
- TIME Magazine
- United Nations Educational Scientific and Cultural Organization
- United States
- USD
Conference on Biobanking Americas ( Conference and Workshop Only )
The future for next generation drug discovery and personalised medicines
To be held at 9th - 11th November 2010, Boston, USA
Conference On Translational Regenerative Medicine (Conference Only)
Submitted by bharatbookseo on Thu, 14/01/2010 - 06:13- Academic Liaison
- Alain Vertes
- Alain Vertes Global Alliance
- Alan Lamont
- Alexander Denoon
- Anthony Hollander
- Anthony Mathur
- AstraZeneca
- Azellon
- Biomaterials
- bioprocessing
- Biotechnology
- cardiovascular diseases
- Cell Biology
- Cell Therapy
- Cell Therapy
- Department of Health
- diabetes
- Dohme Alan Lamont
- F. Hoffmann-La Roche
- Gene Therapies
- gene therapy
- gene therapy
- Great Ormond Street Hospital
- healthcare
- Ireland
- James Lawford Davies
- Jan Lundberg
- Jane Lebkowski
- John Connolly
- Lars Wahlberg
- Lars Wahlberg
- London
- Merck
- Neuroscience F. Hoffmann-La
- Neuroscience
- Paulo Fontoura
- Person Career
- Pfizer Regenerative
- proteomics
- regenerative medicine
- retinal degeneration
- Robert Gaspar
- Robert Lechler
- Robert Pinnock
- Rosemary Drake
- Ruth McKernan
- stem cell therapies
- Stem cells
- Stephen Minger
- The Automation Partnership
- tissue engineering
- United Kingdom
- USD
- venture capital
http://www.bharatbook.com/detail.asp?id=111638&rt=Conference-On-Translat...
Translational Regenerative Medicine
Scaling-up from lab to clinic
To be held on 30th - 31st March 2010, BSG House, London, UK
Background Info
Key Speakers
• Stephen Minger, Senior Lecturer in Stem Cell Biology, King’s College London
Conference on 5th Annual Pharmacovigilance(Conference only)
Submitted by bharatbookseo on Thu, 14/01/2010 - 06:04- AstraZeneca
- Commission of European Communities
- Company Competitor
- Deane Lesley Deane
- drug development
- Drug Safety
- Emma Boulton
- Epidemiology
- Epidemiology - Specialty Care
- EU QPPV
- EU Vigilance
- Europe
- Geneva
- Irene Michas
- Jacques Wodelet
- James Weatherall
- John Parkinson
- John Talbot
- Lesley Deane
- London
- Merck
- New Horizons
- pain
- Paolo Biffignandi
- Person Career
- Pfizer
- pharmaceutical
- Pharmacovigilance Education
- Rachel Sobel
- Saad Shakir
- Schering-Plough
- Seema Jaitly
- Stiefel Laboratories
- United Kingdom
- Woodward
http://www.bharatbook.com/detail.asp?id=129230&rt=Conference-on-5th-Annu...
5th Annual Pharmacovigilance Conference
Implementing best practices in drug safety and surveillance
17th - 19th March 2010, BSG House, London, UK
Background Info
Key Speakers
• Dr Rachel Sobel, Senior Director, Epidemiology - Specialty Care BU Group Head, Pfizer
Conference on 5th Annual Pharmacovigilance(Workshop only)
Submitted by bharatbookseo on Sat, 09/01/2010 - 07:46- AstraZeneca
- Commission of European Communities
- Company Competitor
- Deane Lesley Deane
- drug development
- Drug Safety
- Emma Boulton
- Epidemiology
- Epidemiology - Specialty Care
- EU QPPV
- EU Vigilance
- Europe
- Geneva
- Irene Michas
- Jacques Wodelet
- James Weatherall
- John Parkinson
- John Talbot
- K
- Lesley Deane
- London
- Merck
- New Horizons
- pain
- Paolo Biffignandi
- Person Career
- Pfizer
- pharmaceutical
- Pharmacovigilance Education
- Rachel Sobel
- Saad Shakir
- Schering-Plough
- Seema Jaitly
- Stiefel Laboratories
- United Kingdom
- Woodward
5th Annual Pharmacovigilance Conference
Implementing best practices in drug safety and surveillance
17th - 19th March 2010, BSG House, London, UK
Background Info
Key Speakers
• Dr Rachel Sobel, Senior Director, Epidemiology - Specialty Care BU Group Head, Pfizer
• Seema Jaitly, VP Global Medical & Scientific Affairs, Stiefel Laboratories, GSK
Conference on 5th Annual Pharmacovigilance(Conference and workshop)
Submitted by bharatbookseo on Sat, 09/01/2010 - 07:44- AstraZeneca
- Commission of European Communities
- Company Competitor
- Deane Lesley Deane
- drug development
- Drug Safety
- Emma Boulton
- Epidemiology
- Epidemiology - Specialty Care
- EU QPPV
- EU Vigilance
- Europe
- Geneva
- Irene Michas
- Jacques Wodelet
- James Weatherall
- John Parkinson
- John Talbot
- K
- Lesley Deane
- London
- Merck
- New Horizons
- pain
- Paolo Biffignandi
- Person Career
- Pfizer
- pharmaceutical
- Pharmacovigilance Education
- Rachel Sobel
- Saad Shakir
- Schering-Plough
- Seema Jaitly
- Stiefel Laboratories
- United Kingdom
- Woodward
5th Annual Pharmacovigilance Conference
Implementing best practices in drug safety and surveillance
17th - 19th March 2010, BSG House, London, UK
Background Info
Key Speakers
• Dr Rachel Sobel, Senior Director, Epidemiology - Specialty Care BU Group Head, Pfizer
• Seema Jaitly, VP Global Medical & Scientific Affairs, Stiefel Laboratories, GSK
Conference on 5th Annual Pharmacovigilance(Conference only)
Submitted by bharatbookseo on Mon, 04/01/2010 - 09:05- AstraZeneca
- Commission of European Communities
- Company Competitor
- Deane Lesley Deane
- drug development
- Drug Safety
- Emma Boulton
- Epidemiology
- Epidemiology - Specialty Care
- EU QPPV
- EU Vigilance
- Europe
- Geneva
- Irene Michas
- Jacques Wodelet
- James Weatherall
- John Parkinson
- John Talbot
- K
- Lesley Deane
- Merck
- New Horizons
- pain
- Paolo Biffignandi
- Person Career
- Pfizer
- pharmaceutical
- Pharmacovigilance Education
- Rachel Sobel
- Saad Shakir
- Schering-Plough
- Seema Jaitly
- Stiefel Laboratories
- Woodward
Key Speakers
• Dr Rachel Sobel, Senior Director, Epidemiology - Specialty Care BU Group Head, Pfizer
• Seema Jaitly, VP Global Medical & Scientific Affairs, Stiefel Laboratories, GSK
• Dr John Parkinson, Director, General Practice Research Database (GPRD), MHRA
• Dr John Talbot, Director - Patient Safety, Processes & Standards, AstraZeneca R&D
VWR Layoffs not helping company. Company still bleeding
Submitted by Anonymous on Thu, 15/01/2009 - 00:31The latest round of job cuts at VWR are not helping the oompany as the company continues to see revenue decreases, margin losses and customers leaving. Management is trying to "Save" their way to profitability by cutting cost, mainly people. It will not work it appears.